Medicinal compositions and methods of use involving phosphoric acid esters
US3991187A · kind A · utility
12Cited by
2References
46Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 1974 |
| Grant date | Nov 9, 1976 |
| Priority date | — |
| Expiry date | May 6, 1994 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel symmetrical secondary phosphoric acid esters having the general formula ##SPC1## Wherein the substituent R is positioned in meta or para position relative to the phosphoric acid ester group; processes for the preparation of said esters; and compositions containing said esters. The esters are i.a. useful as selective inhibitors of prostaglandins and compounds with prostaglandin activities. They also selectively antagonize the slow reacting substance (SRS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.